USE AND OUTCOMES OF ANTIARRHYTHMIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING ORAL ANTICOAGULATION: RESULTS FROM THE ROCKET AF TRIAL

Autor:	Kenneth W. Mahaffey, Graeme J. Hankey, Jonathan L. Halperin, Benjamin A. Steinberg, Rod S. Passman, Anne S. Hellkamp, Richard C. Becker, Yuliya Lokhnygina, Christopher C. Nessel, Scott D. Berkowitz, Jonathan P. Piccini, Guenter Breithardt, Keith A.A. Fox, Manesh R. Patel, Daniel E. Singer, Robert M. Califf
Rok vydání:	2014
Předmět:	medicine.medical_specialty business.industry Atrial fibrillation medicine.disease Rocket af Internal medicine Emergency medicine medicine Cardiology In patient business Cardiology and Cardiovascular Medicine Stroke Oral anticoagulation
Zdroj:	ResearcherID
ISSN:	0735-1097
DOI:	10.1016/s0735-1097(14)60327-2
Popis:	Antiarrhythmic drug (AAD) therapy and oral anticoagulation are mainstays of atrial fibrillation (AF) treatment. We studied the use and outcomes of AADs in patients anticoagulated for stroke prophylaxis. Patients randomized in the ROCKET AF trial (n=14,264) were grouped by AAD use at baseline
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82fa14865ee29a814daff14619863f07 Zobrazit plný text záznamu